The Rogel Cancer Center is a distinguished National Cancer Institute comprehensive cancer center. Our commitment to eradicating cancer is driven by pioneering research and collaborations between scientists and clinicians. Our cancer center's focused efforts advance from groundbreaking laboratory investigations to the seamless application of these discoveries in patient care. We offer a variety of programs to support these endeavors. To learn more about each program you can click on the below links and/or click on a program leader's name to send them an email directly.

Programs

Cancer Control and Population Sciences

Program Co-Leaders: 

• Christine Veenstra, M.D.

• C. Leigh Pearce, Ph.D., M.P.H.

• Lauren Wallner, Ph.D., M.P.H. 

Translational and Clinical Research

Program Co-Leaders

• Theodore Lawrence, M.D., Ph.D.

• Joshi Alumkal, M.D. 

• Ulka Vaishampayan, MBBS, FAB 

Cancer Hematopoiesis & Immunology

Program Co-Leaders

• Ryan Wilcox, M.D., Ph.D. 

• Weiping Zou, M.D., Ph.D.

Cancer Genetics Research

Program Co-Leaders

• Sami Malek, Ph.D., 

• Kathy Cho, M.D. 

Signaling and Tumor Microenvironment 

• Program Co-Leaders: 

• Yatrik Shah, Ph.D.,

• Marina Pasca Di Magliano, Ph.D. 

Developmental Therapeutics 

Program Co-Leaders: 

• Jolanta Grembecka, Ph.D., 

• Judith Sebolt-Leopold, Ph.D.